A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects
NCT07476157 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2026-03-17
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects
Conditions
Interventions
- DRUG
-
AD-118, AD-1181
Single-dose oral administration of AD-118 or AD-1181, according to randomized sequence.
Sponsors & Collaborators
-
Addpharma Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
NCT04762407 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers
NCT05155995 ·Status: COMPLETED ·Phase: PHASE1
-
A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations
NCT04338711 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181
NCT02044406 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers
NCT05548387 ·Status: COMPLETED ·Phase: PHASE1
-
Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants
NCT07215078 ·Status: RECRUITING ·Phase: PHASE1
-
Multiple Rising Oral Doses of BI 691751 in Healthy Male Subjects
NCT02148107 ·Status: TERMINATED ·Phase: PHASE1
-
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults
NCT06931327 ·Status: COMPLETED ·Phase: PHASE1
-
NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)
NCT05354713 ·Status: COMPLETED ·Phase: PHASE1
-
Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers
NCT03208218 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects
NCT05103878 ·Status: COMPLETED ·Phase: PHASE1
-
PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR Formulations
NCT03112148 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults
NCT06933459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2
NCT04181437 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers
NCT05132049 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016A" With "BR1016B" in Healthy Volunteers
NCT05102903 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Rising Dose of BI 1181181 Given Orally in Young Healthy Male and Elderly Healthy Male/Female Volunteers
NCT02254161 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC
NCT06471868 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T
NCT05617651 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects
NCT05141110 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy Subjects
NCT01365000 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers
NCT05351840 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers
NCT05463497 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects
NCT05460364 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers
NCT03774355 ·Status: COMPLETED ·Phase: PHASE1